RATIONALE: Evidence links longevity to dietary restriction (DR). A decrease in body temperature (T(b)) is thought to contribute to enhanced longevity because lower T(b) reduces oxidative metabolism and oxidative stress. It is as yet unclear how DR decreases T(b). OBJECTIVE: Here, we test the hypothesis that prolonged DR decreases T(b) by sensitizing adenosine A(1) receptors (A(1)AR) and adenosine-induced cooling. METHODS AND RESULTS: Sprague-Dawley rats were dietary restricted using an every-other-day feeding protocol. Rats were fed every other day for 27 days and then administered the A(1)AR agonist, N(6)-cyclohexyladenosine (CHA; 0.5 mg/kg, i.p.). Respiratory rate (RR) and subcutaneous T(b) measured using IPTT-300 transponders were monitored every day and after drug administration. DR animals displayed lower RR on day 20 and lower T(b) on day 22 compared to animals fed ad libitum and displayed a larger response to CHA. In all cases, RR declined before T(b). Contrary to previous reports, a higher dose of CHA (5 mg/kg, i.p.) was lethal in both dietary groups. We next tested the hypothesis that sensitization to the effects of CHA was due to increased surface expression of A(1)AR within the hypothalamus. We report that the abundance of A(1)AR in the membrane fraction increases in hypothalamus, but not cortex of DR rats. CONCLUSION: These results suggest that every-other-day feeding lowers T(b) via sensitization of thermoregulatory effects of endogenous adenosine by increasing surface expression of A(1)AR. DISCUSSION: Evidence that diet can modulate purinergic signaling has implications for the treatment of stroke, brain injury, epilepsy, and aging.
RATIONALE: Evidence links longevity to dietary restriction (DR). A decrease in body temperature (T(b)) is thought to contribute to enhanced longevity because lower T(b) reduces oxidative metabolism and oxidative stress. It is as yet unclear how DR decreases T(b). OBJECTIVE: Here, we test the hypothesis that prolonged DR decreases T(b) by sensitizing adenosine A(1) receptors (A(1)AR) and adenosine-induced cooling. METHODS AND RESULTS:Sprague-Dawley rats were dietary restricted using an every-other-day feeding protocol. Rats were fed every other day for 27 days and then administered the A(1)AR agonist, N(6)-cyclohexyladenosine (CHA; 0.5 mg/kg, i.p.). Respiratory rate (RR) and subcutaneous T(b) measured using IPTT-300 transponders were monitored every day and after drug administration. DR animals displayed lower RR on day 20 and lower T(b) on day 22 compared to animals fed ad libitum and displayed a larger response to CHA. In all cases, RR declined before T(b). Contrary to previous reports, a higher dose of CHA (5 mg/kg, i.p.) was lethal in both dietary groups. We next tested the hypothesis that sensitization to the effects of CHA was due to increased surface expression of A(1)AR within the hypothalamus. We report that the abundance of A(1)AR in the membrane fraction increases in hypothalamus, but not cortex of DRrats. CONCLUSION: These results suggest that every-other-day feeding lowers T(b) via sensitization of thermoregulatory effects of endogenous adenosine by increasing surface expression of A(1)AR. DISCUSSION: Evidence that diet can modulate purinergic signaling has implications for the treatment of stroke, brain injury, epilepsy, and aging.
Authors: Rafael Franco; Francisco Ciruela; Vicent Casadó; Antonio Cortes; Enric I Canela; Josefa Mallol; Luigi F Agnati; Sergi Ferré; Kjell Fuxe; Carmen Lluis Journal: J Mol Neurosci Date: 2005 Impact factor: 3.444
Authors: David Elmenhorst; Philipp T Meyer; Oliver H Winz; Andreas Matusch; Johannes Ermert; Heinz H Coenen; Radhika Basheer; Helmut L Haas; Karl Zilles; Andreas Bauer Journal: J Neurosci Date: 2007-02-28 Impact factor: 6.167
Authors: Bruno Conti; Manuel Sanchez-Alavez; Raphaelle Winsky-Sommerer; Maria Concetta Morale; Jacinta Lucero; Sara Brownell; Veronique Fabre; Salvador Huitron-Resendiz; Steven Henriksen; Eric P Zorrilla; Luis de Lecea; Tamas Bartfai Journal: Science Date: 2006-11-03 Impact factor: 47.728
Authors: Kelly L Drew; C Loren Buck; Brian M Barnes; Sherri L Christian; Brian T Rasley; Michael B Harris Journal: J Neurochem Date: 2007-06-06 Impact factor: 5.372
Authors: Lori-An V Etherington; Graham E Patterson; Louise Meechan; Detlev Boison; Andrew J Irving; Nicholas Dale; Bruno G Frenguelli Journal: Neuropharmacology Date: 2008-10-10 Impact factor: 5.250
Authors: Jesse Lea Carlin; Shalini Jain; Elizabeth Gizewski; Tina C Wan; Dilip K Tosh; Cuiying Xiao; John A Auchampach; Kenneth A Jacobson; Oksana Gavrilova; Marc L Reitman Journal: Neuropharmacology Date: 2016-11-30 Impact factor: 5.250
Authors: Isaac R Bailey; Bernard Laughlin; Lucille A Moore; Lori K Bogren; Zeinab Barati; Kelly L Drew Journal: J Pharmacol Exp Ther Date: 2017-06-26 Impact factor: 4.030
Authors: Jasmine M Olson; Tulasi R Jinka; Lindy K Larson; Jeffrey J Danielson; Jeanette T Moore; Joanna Carpluck; Kelly L Drew Journal: J Biol Rhythms Date: 2013-06 Impact factor: 3.182